Kaken Pharmaceutial

4521.TPharmaceutical
Filed as KAKEN PHARMACEUTICAL CO., LTD. (2022-06–2026-06)
Major holders (5%+) · 0
HolderStakeChangeFiled

No holder currently reports 5% or more.

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 7
―4.95%2024-11-26
―4.95%2024-11-26
―4.95%2024-11-26
Silchester International Investors LLP4.82%2024-03-27
Mizuho Bank, Ltd.3.34%2026-08-07
Asset Management One Co., Ltd.1.29%2026-08-07
Mizuho Trust & Banking Co., Ltd.0.45%2026-08-07
Ownership history · 10
FiledHolderRatioChangePurpose
2026-08-07Mizuho Trust & Banking Co., Ltd.2026-08-070.45%newAsset management / investment
2026-08-07Asset Management One Co., Ltd.2026-08-071.29%newHeld for clients (discretionary / trust)
2026-08-07Mizuho Bank, Ltd.2026-08-073.34%newBusiness / capital relationship
2024-06-05Amended―2024-06-05 · amended0.07%+0.07ppMaterial proposals to management (activist)
2024-06-05Amended―2024-06-05 · amended0.81%-0.27ppMaterial proposals to management (activist)
2024-06-05Amended―2024-06-05 · amended4.07%-0.96ppMaterial proposals to management (activist)
2024-06-05Amended―2024-06-05 · amended0.00%newMaterial proposals to management (activist)
2024-06-05Amended―2024-06-05 · amended1.08%newMaterial proposals to management (activist)
2024-06-05Amended―2024-06-05 · amended5.03%newMaterial proposals to management (activist)
2024-03-27AmendedSilchester International Investors LLP2024-03-27 · amended4.82%newHeld for clients (discretionary / trust)

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.